Literature DB >> 32183209

Better Adjuvants for Better Vaccines: Progress in Adjuvant Delivery Systems, Modifications, and Adjuvant-Antigen Codelivery.

Zhi-Biao Wang1, Jing Xu1.   

Abstract

Traditional aluminum adjuvants can trigger strong humoral immunity but weak cellular immunity, limiting their application in some vaccines. Currently, various immunomodulators and delivery carriers are used as adjuvants, and the mechanisms of action of some of these adjuvants are clear. However, customizing targets of adjuvant action (cellular or humoral immunity) and action intensity (enhancement or inhibition) according to different antigens selected is time-consuming. Here, we review the adjuvant effects of some delivery systems and immune stimulants. In addition, to improve the safety, effectiveness, and accessibility of adjuvants, new trends in adjuvant development and their modification strategies are discussed.

Entities:  

Keywords:  adjuvant; immune response; immunogenicity; vaccine

Year:  2020        PMID: 32183209     DOI: 10.3390/vaccines8010128

Source DB:  PubMed          Journal:  Vaccines (Basel)        ISSN: 2076-393X


  29 in total

1.  Narcolepsy risk and COVID-19.

Authors:  Emmanuel Mignot; Steve Black
Journal:  J Clin Sleep Med       Date:  2020-10-15       Impact factor: 4.062

Review 2.  Structurally Modified Plant Viruses and Bacteriophages with Helical Structure. Properties and Applications.

Authors:  Olga A Kondakova; Ekaterina A Evtushenko; Oleg A Baranov; Nikolai A Nikitin; Olga V Karpova
Journal:  Biochemistry (Mosc)       Date:  2022-06       Impact factor: 2.824

Review 3.  Rational Vaccinology: Harnessing Nanoscale Chemical Design for Cancer Immunotherapy.

Authors:  Ziyin Huang; Cassandra E Callmann; Shuya Wang; Matthew K Vasher; Michael Evangelopoulos; Sarah Hurst Petrosko; Chad A Mirkin
Journal:  ACS Cent Sci       Date:  2022-05-20       Impact factor: 18.728

4.  Simultaneous testing of immunological sensitization to multiple antigens in sarcoidosis reveals an association with inorganic antigens specifically related to a fibrotic phenotype.

Authors:  E Beijer; R Kraaijvanger; C Roodenburg; J C Grutters; B Meek; M Veltkamp
Journal:  Clin Exp Immunol       Date:  2020-10-06       Impact factor: 4.330

5.  Immunization using ApoB-100 peptide-linked nanoparticles reduces atherosclerosis.

Authors:  Kuang-Yuh Chyu; Xiaoning Zhao; Jianchang Zhou; Paul C Dimayuga; Nicole Wm Lio; Bojan Cercek; Noah T Trac; Eun Ji Chung; Prediman K Shah
Journal:  JCI Insight       Date:  2022-06-08

Review 6.  COVID-19 Vaccine Frontrunners and Their Nanotechnology Design.

Authors:  Young Hun Chung; Veronique Beiss; Steven N Fiering; Nicole F Steinmetz
Journal:  ACS Nano       Date:  2020-10-09       Impact factor: 15.881

Review 7.  Phototherapy as a Rational Antioxidant Treatment Modality in COVID-19 Management; New Concept and Strategic Approach: Critical Review.

Authors:  Reem Hanna; Snehal Dalvi; Tudor Sălăgean; Ioana Roxana Bordea; Stefano Benedicenti
Journal:  Antioxidants (Basel)       Date:  2020-09-16

Review 8.  Recent strategies for nano-based PTT combined with immunotherapy: from a biomaterial point of view.

Authors:  Xingyue Huang; Yang Lu; Mingxue Guo; Shouying Du; Ning Han
Journal:  Theranostics       Date:  2021-06-04       Impact factor: 11.556

Review 9.  Cancer Vaccines: Promising Therapeutics or an Unattainable Dream.

Authors:  Howard Donninger; Chi Li; John W Eaton; Kavitha Yaddanapudi
Journal:  Vaccines (Basel)       Date:  2021-06-18

Review 10.  Chemical Conjugation Strategies for the Development of Protein-Based Subunit Nanovaccines.

Authors:  Lantian Lu; Viet Tram Duong; Ahmed O Shalash; Mariusz Skwarczynski; Istvan Toth
Journal:  Vaccines (Basel)       Date:  2021-05-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.